Private company

GlySens ICGM

Long term surgically inserted glucose monitor based in San Diego1

GlySens, a biomedical technology company, is a privately owned corporation developing a long term internal continuous glucose monitor in order to effectively manage and observe glucose levels in real time. In preclinical testing, the system was evaluated for operational performance over an 18-month period.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

  • Industryhealth care1
  • HeadquartersSan Diego1

GlySens, a biomedical technology company, is a privately owned corporation developing a long term internal continuous glucose monitor in order to effectively manage and observe glucose levels in real time. In preclinical testing, the system was evaluated for operational performance over an 18-month period.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2